請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/8642完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳敏慧(Min-Huey Chen) | |
| dc.contributor.author | Ko-Li Ku | en |
| dc.contributor.author | 顧可立 | zh_TW |
| dc.date.accessioned | 2021-05-20T19:59:12Z | - |
| dc.date.available | 2011-09-09 | |
| dc.date.available | 2021-05-20T19:59:12Z | - |
| dc.date.copyright | 2010-09-09 | |
| dc.date.issued | 2010 | |
| dc.date.submitted | 2010-06-23 | |
| dc.identifier.citation | 1. Agostini, C. (1976). 'Hexosamine content found in serum and ascitic fluid of the rat during the development of yoshida ascites hepatoma cells.' IRCS Med Sci,Libr Compend(4): 400-3.
2. Boorjian, S. A., Y. Sheinin, et al. (2008). 'T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival.' Clin Cancer Res 14(15): 4800-8. 3. Burchell, J. M., A. Mungul, et al. (2001). 'O-linked glycosylation in the mammary gland: changes that occur during malignancy.' J Mammary Gland Biol Neoplasia 6(3): 355-64. 4. Burket, L. W. (1954). 'Oral medicine.' Merck Rep 63(2): 16-9. 5. Castriconi, R., A. Dondero, et al. (2004). 'Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis.' Proc Natl Acad Sci U S A 101(34): 12640-5. 6. Chang, W. W., C. Y. Yu, et al. (2006). 'Soyasaponin I decreases the expression of alpha2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells.' Biochem Biophys Res Commun 341(2): 614-9. 7. Chapoval, A. I., J. Ni, et al. (2001). 'B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.' Nat Immunol 2(3): 269-74. 8. Chavin, G., Y. Sheinin, et al. (2009). 'Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases.' Clin Cancer Res 15(6): 2174-80. 9. Chen, C. (1987). 'An epidemiology study of oral squamous cell carcinoma in sounthern Taiwan.' J Formosan Dent Assoc. 10: 268-74. 10. Chen, Y. W., C. Tekle, et al. (2008). 'The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion.' Curr Cancer Drug Targets 8(5): 404-13. 11. Crispen, P. L., Y. Sheinin, et al. (2008). 'Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma.' Clin Cancer Res 14(16): 5150-7. 12. Dabelsteen, E., H. Clausen, et al. (1991). 'Aberrant glycosylation in oral malignant and premalignant lesions.' J Oral Pathol Med 20(8): 361-8. 13. Dennis, J. W., M. Granovsky, et al. (1999). 'Glycoprotein glycosylation and cancer progression.' Biochim Biophys Acta 1473(1): 21-34. 14. Drickamer K, T. M. (2006). 'Introduction to glycobiology, 2nd edn.' Oxford University Press: Oxford, UK. 15. Egawa, N., N. Koshikawa, et al. (2006). 'Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells.' J Biol Chem 281(49): 37576-85. 16. Eskinnazi, D. (1987). 'Oncogenic potential of sexually transmitted viruses with special references to oral cancer.' Oral Surg Oral Med Oral Pathol 64: 35-40. 17. Feijoo, C., M. Paez de la Cadena, et al. (1997). 'Sialic acid levels in serum and tissue from colorectal cancer patients.' Cancer Lett 112(2): 155-60. 18. Fidler, I. J., D. M. Gersten, et al. (1977). 'Relationship of host immune status to tumor cell arrest, distribution, and survival in experimental metastasis.' Cancer 40(1): 46-55. 19. Flies, D. B. and L. Chen (2007). 'The new B7s: playing a pivotal role in tumor immunity.' J Immunother 30(3): 251-60. 20. Goldhirsch, A., E. Berger, et al. (1998). 'Ovarian cancer and tumor marker: sialic acid, galactosyl transferase and CA-125.' Oncology 45: 281-6. 21. Gron, B., A. Andersson, et al. (1999). 'Blood-group-related carbohydrates are expressed in organotypic cultures of human skin and oral mucosa.' APMIS 107(8): 779-90. 22. Hakomori, S. (1981). 'Glycosphingolipids in cellular interaction, differentiation, and oncogenesis.' Annu Rev Biochem 50: 733-64. 23. Hanson, S. R., T. L. Hsu, et al. (2007). 'Tailored glycoproteomics and glycan site mapping using saccharide-selective bioorthogonal probes.' J Am Chem Soc 129(23): 7266-7. 24. Hardisson, D. (2003). 'Molecular pathogenesis of head and neck squamous cell carcinoma.' Eur Arch Otorhinolaryngol 260(9): 502-8. 25. Hashiguchi, M., H. Kobori, et al. (2008). 'Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses.' Proc Natl Acad Sci U S A 105(30): 10495-500. 26. Hickey, R., R. Clark, et al. (1986). 'Year book of cancer.' Chicago: Yearbook, Medical Pubilshers: 427. 27. Hofmeyer, K. A., A. Ray, et al. (2008). 'The contrasting role of B7-H3.' Proc Natl Acad Sci U S A 105(30): 10277-8. 28. Hollingsworth, M. A. and B. J. Swanson (2004). 'Mucins in cancer: protection and control of the cell surface.' Nat Rev Cancer 4(1): 45-60. 29. Hsu, C. C., T. W. Lin, et al. (2005). 'Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids.' Gynecol Oncol 96(2): 415-22. 30. Hsu, T. L., S. R. Hanson, et al. (2007). 'Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells.' Proc Natl Acad Sci U S A 104(8): 2614-9. 31. Krogh, P., B. Hald, et al. (1987). 'Possible mycological etiology of oral cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine.' Cacinogenesis 8: 1543-8. 32. Kumar V, C. R., Robbins SL (1997). 'Basic Pathology ' 6th ed, WB Saunder Co, Philadelphia: 473-474. 33. Ling, V., P. W. Wu, et al. (2003). 'Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss.' Genomics 82(3): 365-77. 34. Lippman, S. M., J. Sudbo, et al. (2005). 'Oral cancer prevention and the evolution of molecular-targeted drug development.' J Clin Oncol 23(2): 346-56. 35. Luo, L., A. I. Chapoval, et al. (2004). 'B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells.' J Immunol 173(9): 5445-50. 36. Lupu, C. M., C. Eisenbach, et al. (2007). 'Adenoviral B7-H3 therapy induces tumor specific immune responses and reduces secondary metastasis in a murine model of colon cancer.' Oncol Rep 18(3): 745-8. 37. Macbeth, R. A. and J. G. Bekesi (1964). 'Plasma Glycoproteins in Malignant Disease.' Arch Surg 88: 633-7. 38. Manoharan, S., M. Padmanabhan, et al. (2004). 'Analysis of glycoconjugates in patients with oral squamous cell carcinoma.' Clin Chim Acta 339(1-2): 91-6. 39. Modak, S., K. Kramer, et al. (2001). 'Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.' Cancer Res 61(10): 4048-54. 40. Moh, M. C., C. Zhang, et al. (2005). 'Structural and functional analyses of a novel ig-like cell adhesion molecule, hepaCAM, in the human breast carcinoma MCF7 cells.' J Biol Chem 280(29): 27366-74. 41. Narayanan, S. (1994). 'Sialic acid as a tumor marker.' Ann Clin Lab Sci 24(4): 376-84. 42. Nicolson, G. L. (1984). 'Cell surface molecules and tumor metastasis. Regulation of metastatic phenotypic diversity.' Exp Cell Res 150(1): 3-22. 43. Oliver, R. J., D. G. MacDonald, et al. (2000). 'Aspects of cell proliferation in oral epithelial dysplastic lesions.' J Oral Pathol Med 29(2): 49-55. 44. Ossowaki, L. (1988). 'In vivo invasion of modified choroallantoic membrane by tumor cells: the role of cell surface-bound Urokinase.' J Cell Biolo 107: 2437. 45. Parkin, D. M., F. Bray, et al. (2005). 'Global cancer statistics, 2002.' CA Cancer J Clin 55(2): 74-108. 46. Paszkowska, A., H. Berbec, et al. (1998). 'Sialic acid concentration in serum and tissue of endometrial cancer patients.' Eur J Obstet Gynecol Reprod Biol 76(2): 211-5. 47. Patel, P. S., S. G. Adhvaryu, et al. (1994). 'Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias.' Anticancer Res 14(2B): 747-51. 48. Pindborg, J. J. (1980). 'Oral cancer and precancer.' 49. Prasad, D. V., T. Nguyen, et al. (2004). 'Murine B7-H3 is a negative regulator of T cells.' J Immunol 173(4): 2500-6. 50. Ranasinghe, A. W., K. A. Warnakulasuriya, et al. (1993). 'Low prevalence of expression of p53 oncoprotein in oral carcinomas from Sri Lanka associated with betel and tobacco chewing.' Eur J Cancer B Oral Oncol 29B(2): 147-50. 51. Rich, J. R. and S. G. Withers (2009). 'Emerging methods for the production of homogeneous human glycoproteins.' Nat Chem Biol 5(4): 206-15. 52. Rollo, J., C. V. Rozenbom, et al. (1981). 'Squamous carcinoma of the base of the tongue: a clinicopathologic study of 81 cases.' Cancer 47(2): 333-42. 53. Rosenberg, C. D., S. Ferrone, et al. (1990). 'Interspecific DNA-mediated transfer and amplification of a gene specifying a Mr 100,000 human melanoma-associated cell surface glycoprotein.' Cancer Res 50(5): 1559-65. 54. Roth, T. J., Y. Sheinin, et al. (2007). 'B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy.' Cancer Res 67(16): 7893-900. 55. Schutter, E. M., J. J. Visser, et al. (1992). 'The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.' Tumour Biol 13(3): 121-32. 56. Scuibba, J. (2001). 'Oral Cancer.' Am J Clin Dermatol 2(4): 239-51. 57. Scully, C. and D. H. Felix (2006). 'Oral medicine--update for the dental practitioner orofacial pain.' Br Dent J 200(2): 75-83. 58. Seeger, R. C., H. M. Rosenblatt, et al. (1981). 'Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.' Cancer Res 41(7): 2714-7. 59. Shah, J. P., F. C. Candela, et al. (1990). 'The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity.' Cancer 66(1): 109-13. 60. Shah, M. H., S. D. Telang, et al. (2008). 'Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis.' Glycoconj J 25(3): 279-90. 61. Sliverberg, E. and J. Lubera (1992). 'Cancer statistics.' (CA 40): 5-22. 62. Steinberger, P., O. Majdic, et al. (2004). 'Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains.' J Immunol 172(4): 2352-9. 63. Sugarbaker, E. V. (1979). 'Current problems in cancer.' Yearbook medical publishers. Chicago.: 3-59. 64. Suh, W. K., B. U. Gajewska, et al. (2003). 'The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses.' Nat Immunol 4(9): 899-906. 65. Sun, M., S. Richards, et al. (2002). 'Characterization of mouse and human B7-H3 genes.' J Immunol 168(12): 6294-7. 66. Sun, X., M. Vale, et al. (2003). 'Mouse B7-H3 induces antitumor immunity.' Gene Ther 10(20): 1728-34. 67. Sun, Y., Y. Wang, et al. (2006). 'B7-H3 and B7-H4 expression in non-small-cell lung cancer.' Lung Cancer 53(2): 143-51. 68. Suyama, K., I. Shapiro, et al. (2002). 'A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor.' Cancer Cell 2(4): 301-14. 69. Takei, K., T. Inoue, et al. (1989). '[A statistical study of autopsies performed on cases of oral cancer: with reference to distant metastasis in tongue cancer].' Shikwa Gakuho 89(3): 627-38. 70. Varki A, C. R., Esko JD, et al (1999). 'Essential of glycobiology.' Cold Spring Harbor Laboratory Press: Plainview, NY. 71. Varki, N. M. and A. Varki (2007). 'Diversity in cell surface sialic acid presentations: implications for biology and disease.' Lab Invest 87(9): 851-7. 72. Vokes, E. E., R. R. Weichselbaum, et al. (1993). 'Head and neck cancer.' N Engl J Med 328(3): 184-94. 73. Wu, C. P., J. T. Jiang, et al. (2006). 'Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis.' World J Gastroenterol 12(3): 457-9. 74. Xing, R. D., Z. S. Wang, et al. (1994). 'Total sialic acid as a tumor marker for oral cancer.' Int J Biol Markers 9(4): 239-42. 75. Yogeeswaran, G., A. Gronberg, et al. (1981). 'Correlation of glycosphingolipids and sialic acid in YAC-1 lymphoma variants with their sensitivity to natural killer-cell-mediated lysis.' Int J Cancer 28(4): 517-26. 76. Yogeeswaran, G. and P. L. Salk (1981). 'Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines.' Science 212(4502): 1514-6. 77. Zang, X., R. H. Thompson, et al. (2007). 'B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome.' Proc Natl Acad Sci U S A 104(49): 19458-63. 78. Zhang, G. B., Y. J. Chen, et al. (2004). 'Human recombinant B7-H3 expressed in E. coli enhances T lymphocyte proliferation and IL-10 secretion in vitro.' Acta Biochim Biophys Sin (Shanghai) 36(6): 430-6. 79. Zhang, G. B., H. Zhou, et al. (2005). 'Characterization and application of two novel monoclonal antibodies against 2IgB7-H3: expression analysis of 2IgB7-H3 on dendritic cells and tumor cells.' Tissue Antigens 66(2): 83-92. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/8642 | - |
| dc.description.abstract | 口腔癌居全球癌症發病率及死亡率的第六名，且每年的死亡率不斷的攀升，而當口腔癌發生轉移時，能治癒的機會又是微乎其微，因此，研究口腔癌轉移的機制是非常重要的。近年來的研究發現在許多癌症中，醣蛋白B7H3會有過量的表現，且這些表現可能與癌症的癌化 (cancer progression)、轉移以及低存活率有關。B7H3是一種位於細胞膜上的醣蛋白，除了會表現於免疫細胞，許多癌細胞也有B7H3蛋白的表現。本實驗主要探討口腔鱗狀細胞癌細胞株中B7H3的表現量，並以siRNA將B7H3抑制後，觀察癌細胞的移動、貼附以及增生能力是否改變。
首先，由西方墨點法發現口腔癌細胞株Ca-9-22、SAS、CAL27以及HSC3的醣蛋白表現普遍比正常細胞S-G多，之後藉由質譜儀分析以及西方墨點法找出並確定B7H3在口腔癌細胞株有大量的蛋白質表現。為了更進一步探討B7H3於癌細胞株的作用為何，本實驗利用siRNA轉染的方式抑制癌細胞Ca9-22和SAS表現B7H3，並觀察此處理對癌細胞株移動、貼附以及增生能力的影響。本實驗首先以細胞傷口癒合分析 (wound healing assay)觀察細胞的平移能力，發現轉染後細胞的平移能力有下降。接著利用細胞遷移能力分析 (migration assay) 以及侵襲能力 (invasion assay) 進行分析，結果顯示B7H3抑制後對癌細胞株Ca9-22以及SAS的遷移和侵襲能力是有抑制效果的。在細胞貼附能力方面，Ca9-22和SAS癌細胞株對fibronectin與laminin的貼附能力有下降的趨勢，而在collagen Ⅳ方面的貼附能力雖然有降低，但於統計上並無顯著差異 (p > 0.05)。另外，細胞增生實驗 (MTT assay) 的結果顯示，B7H3對細胞的增生能力並沒有影響。總結上述實驗結果可知，醣蛋白B7H3對口腔癌轉移可能扮演著重要的角色，極有潛力成為口腔癌轉移的標記而對其診斷治療有很大的幫助。 | zh_TW |
| dc.description.abstract | The incidence and mortality of oral cancer is the sixth in the worldwide, and the mortality is continuing rising each year. Once metastasis is occurred in oral cancer, the opportunity for patient to be cured becomes indistinct. Therefore, investigating of the mechanism of oral cancer metastasis is very important. There are some studies report the over-expression of glycoprotein B7H3 in many cancers. It was also indicated that the over-expression of B7H3 might be related with the progression, metastasis, and low survival rate of cancer. B7H3 is a membrane glycoprotein, it can be expressed in immune cells and many cancer cells. In this study, the expression of B7H3 in oral squamous cell carcinoma cell lines was investigated. Small interfering RNA (siRNA) was applied for inhibiting the expression of B7H3 and the changes of mobility, adhesion, and proliferation of cancer cells were also investigated.
In this study, we found that the expression of glycoprotein in Ca-9-22, SAS, CAL27, HSC3 oral cancer cells is more than that in S-G normal cells with significant difference. Identification and confirmation of glycoprotein B7H3 was performed by mass analysis and western blot analysis. For further investigating the function of B7H3 in cancer cells, siRNA was transfected into cancer cells in Ca9-22 and SAS to knockdown B7H3, and the changes of the ability of mobility, adhesion, and proliferation of cancer cells were observed. The results of wound healing assay showed that the migration ability of transfected cells were lower than that of control cancer cells without siRNA transfection. Furthermore, migration and invasion assay also showed that B7H3 knockdown could reduce the migration and invasion potentials of Ca9-22 and SAS cancer cells. It was also found that cell adhesion in fibronectin and laminin is decreased. Whether B7H3 was knockdown in cancer cells, there is no significant effect on adhesion to collagen Ⅳ (p > 0.05). Besides, the MTT data showed that B7H3 has no effect on cell proliferation. In conclusion, glycoprotein B7H3 plays an important role in oral cancer cells especially in cell migration and invasion. We suggest that B7H3 is a potential marker and might be useful for oral cancer therapy. | en |
| dc.description.provenance | Made available in DSpace on 2021-05-20T19:59:12Z (GMT). No. of bitstreams: 1 ntu-99-R97450008-1.pdf: 2385375 bytes, checksum: a60fb3ffa25a07f43df3dd84df515d5b (MD5) Previous issue date: 2010 | en |
| dc.description.tableofcontents | ˙目錄 Ⅰ
˙表次目錄 III ˙圖次目錄 IV ˙Protocol目錄 VI ˙中文摘要 VII ˙英文摘要 VIII 第一章 引言 1 1.癌症的發生 1 2.頭頸部癌症 1 3.口腔癌 1 4.癌症的轉移 6 5.口腔鱗狀細胞癌 7 6.醣蛋白 8 7.B7H3 10 第二章 實驗目的 14 第三章 材料與方法 15 1.細胞培養 15 2.醣蛋白的標定及偵測 15 3.小干擾RNA的轉染 19 4.西方墨點法 20 5.基因表現分析 23 6.細胞傷口癒合分析 25 7.細胞遷移能力分析 25 8.細胞侵襲能力分析 25 9.細胞貼附分析 26 10.細胞增生試驗 26 11.統計分析 27 第四章 結果 28 1.醣蛋白於口腔癌細胞及正常細胞表現的差異 28 2.利用質譜儀分析找出在口腔癌細胞表現較強的醣蛋白 28 3.B7H3蛋白質表現 28 4.B7H3在不同口腔癌細胞的蛋白質表現情形 29 5.siRNA轉染 29 6.口腔癌細胞傷口癒合分析 30 7.口腔癌細胞遷移能力分析 30 8.口腔癌細胞侵襲能力分析 31 9.口腔癌細胞貼附分析 31 10.口腔癌細胞增生試驗 32 第五章 討論 33 1.醣蛋白與癌症的關聯性 33 2.B7H3對癌細胞的影響 33 3.癌症與醣化有關 35 第六章 結論 38 第七章 未來研究方向 40 參考資料 41 附錄 (表、圖與protocol) 49 表次目錄 III 附表1、醣蛋白經過質譜儀分析的結果 49 附表2、本篇實驗所用到的引子序列、黏合溫度與延伸循環次數50 圖次目錄 IV 圖1、醣蛋白之醣基 51 圖2、醣蛋白B7H3的家族 52 圖3、ManNAc與ManNAcyne的結構 53 圖4、醣蛋白的標定與偵測之簡易實驗流程 54 圖5、siRNA的特徵與作用機制 55 圖6、利用西方墨點法比較醣蛋白在口腔癌細胞株與正常細胞株的表 現 56 圖7、以西方墨點法確認細胞有表現B7H3蛋白，並比較口腔癌細胞株與正常細胞株的B7H3蛋白質表現量，再進行統計分析 57 圖8、比較正常細胞株與多種癌細胞株之B7H3蛋白質表現量 58 圖9、siRNA經轉染進入細胞的情形之觀察 59 圖10、siRNA劑量對B7H3的抑制效果之觀察 60 圖11、siRNA抑制B7H3蛋白質及基因表現之觀察 61 圖12、醣蛋白B7H3被抑制後，細胞平移能力改變之觀察 62 圖13、口腔癌細胞在0 % FBS及2% FBS中遷移能力之觀察，決定適合癌細胞進行遷移能力分析的時間 63 圖14、觀察B7H3抑制後對口腔癌細胞遷移能力之影響 64 圖15、觀察B7H3抑制後對口腔癌細胞侵襲能力之影響 65 圖16、觀察B7H3抑制後對口腔癌細胞株Ca9-22貼附能力之影響 66 圖17、觀察B7H3抑制後對口腔癌細胞株SAS貼附能力之影響 67 圖18、觀察B7H3抑制後對口腔癌細胞增生能力之影響 68 Protocol目錄 VI Protocol 1、siRNA的轉染 69 Protocol 2、總蛋白質定量 70 Protocol 3、Western blot 72 Protocol 4、RNA之萃取 75 Protocol 5、染色 (adhesion、migration、invasion) 76 Protocol 6、MTT assay 77 | |
| dc.language.iso | zh-TW | |
| dc.title | 醣蛋白B7H3在口腔癌細胞的表現與作用 | zh_TW |
| dc.title | Expression and Effects of Glycoprotein B7H3 in Oral Cancer Cells | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 98-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 周涵怡(Han-Yi Chou),林劭品(Shau-Ping Lin) | |
| dc.subject.keyword | 口腔癌,醣蛋白,B7H3,siRNA,細胞轉移,細胞侵襲,細胞貼附, | zh_TW |
| dc.subject.keyword | oral cancer,glycoprotein,B7H3,siRNA,migration,invasion,adhesion, | en |
| dc.relation.page | 77 | |
| dc.rights.note | 同意授權(全球公開) | |
| dc.date.accepted | 2010-06-23 | |
| dc.contributor.author-college | 牙醫專業學院 | zh_TW |
| dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
| 顯示於系所單位： | 口腔生物科學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-99-1.pdf | 2.33 MB | Adobe PDF | 檢視/開啟 |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。